Leonardo M. Fabbri
- Long-term macrolide treatment for chronic respiratory diseaseBy Paolo Spagnolo, Leonardo M. Fabbri and Andrew BushPaolo Spagnolo1Section of Respiratory Diseases, Dept of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, ItalyLeonardo M. Fabbri1Section of Respiratory Diseases, Dept of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, ItalyAndrew Bush2Imperial College and Royal Brompton Harefield NHS Foundation Trust, London, UK
- Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPDBy Bianca Beghé, Alessia Verduri, Mihai Roca and Leonardo M. FabbriBianca Beghé*Section of Respiratory Diseases, Dept of Oncology Haematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, ItalyAlessia Verduri*Section of Respiratory Diseases, Dept of Oncology Haematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, ItalyMihai Roca#Faculty of Medicine, Dept of Pneumology, “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Iasi, RomaniaLeonardo M. Fabbri*Section of Respiratory Diseases, Dept of Oncology Haematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy
- FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohortsBy Alvar Agusti, Suzanne Hurd, Paul Jones, Leonardo M. Fabbri, Fernando Martinez, Claus Vogelmeier, Jørgen Vestbo and Robert Rodriguez-RoisinAlvar Agusti1Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona2FISIB, CIBER Enfermedades Respiratorias (CIBERES), Mallorca, SpainSuzanne Hurd3Global Initiative for Chronic Obstructive Lung Disease, Vancouver, WAPaul Jones4St George’s Hospital Medical School, LondonLeonardo M. Fabbri5University of Modena and Reggio Emilia, Modena, ItalyFernando Martinez6University of Michigan School of Medicine, Ann Arbor, MI, USAClaus Vogelmeier7Dept of Respiratory Medicine, University of Marburg, Marburg, GermanyJørgen Vestbo8Manchester Academic Health Sciences Centre, South Manchester University Hospital NHS Foundation Trust, Manchester, UK9Odense University Hospital, Odense10University of Southern Denmark, Odense, DenmarkRobert Rodriguez-Roisin1Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona
- Tiotropium vs salmeterol in GOLD II and maintenance-naïve COPD patients: Subgroup analyses of POET-COPD™ trialBy Kai M. Beeh, Claus Vogelmeier, Maureen P.M.H. Rutten-van Mölken, Klaus F. Rabe, Thomas Glaab, Fee Rühmkorf, Hendrik Schmidt and Leonardo M. FabbriKai M. Beeh1Dept of Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, D 65187 Wiesbaden, GermanyClaus Vogelmeier2Division for Pulmonary Diseases, Hospital of the Universities of Giessen and Marburg, Marburg, GermanyMaureen P.M.H. Rutten-van Mölken3Dept of Health Economics, Institute for Medical Technology Assessment (IMTA), Erasmus University, Rotterdam, NetherlandsKlaus F. Rabe4Dept of Pneumologie, Grosshansdorf Hospital, Grosshansdorf, GermanyThomas Glaab5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyFee Rühmkorf5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyHendrik Schmidt5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyLeonardo M. Fabbri6Dept of Medical and Surgical Specialties, University of Modena & Reggio Emilia, Modena, Italy
- Do exacerbation outcomes in the POET-COPD™ trial differ between regions?By Maureen P.M.H. Rutten-van Mölken, Leonardo M. Fabbri, Klaus F. Rabe, Harald Kögler, Thomas Glaab, Hendrik Schmidt, Kai M. Beeh and Claus VogelmeierMaureen P.M.H. Rutten-van Mölken1Department of Health Economics, Institute for Medical Technology Assessment (IMTA), Erasmus University, Rotterdam, NetherlandsLeonardo M. Fabbri2Department of Medical and Surgical Specialties, University of Modena & Reggio Emilia, Modena, ItalyKlaus F. Rabe3Department of Pneumologie, Grosshansdorf Hospital, Grosshansdorf, GermanyHarald Kögler4Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyThomas Glaab4Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyHendrik Schmidt4Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyKai M. Beeh5Department of Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, Wiesbaden, GermanyClaus Vogelmeier6Division for Pulmonary Diseases, Hospital of the Universities of Giessen and Marburg, Marburg, Germany
- Baseline characteristics of patients with frequent exacerbations in the POET-COPD™ trialBy Leonardo M. Fabbri, Claus Vogelmeier, Maureen P.M.H. Rutten-van Mölken, Klaus F. Rabe, Thomas Glaab, Fee Rühmkorf, Hendrik Schmidt and Kai M. BeehLeonardo M. Fabbri1Dept. of Medical & Surgical Specialities, University of Modena & Reggio Emilia, Modena, ItalyClaus Vogelmeier2Division of Pulmonary Diseases, Hospital of the Universities of Giessen and Marburg, Marburg, GermanyMaureen P.M.H. Rutten-van Mölken3Dept. of Health Economics, Institute for Medical Technology Assessment (IMTA), Erasmus University, Rotterdam, NetherlandsKlaus F. Rabe4Dept. of Pneumologie, Grosshansdorf Hospital, Grosshansdorf, GermanyThomas Glaab5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyFee Rühmkorf5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyHendrik Schmidt5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyKai M. Beeh6Dept. of Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, Wiesbaden, Germany
- Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patientsBy Alessia Verduri, Barbara Bottazzi, Chiara Leuzzi, Roberto D'Amico, Piera Boschetto, Maria Grazia Modena, Alberto Mantovani, Leonardo M. Fabbri and Bianca BeghéAlessia Verduri1Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, ItalyBarbara Bottazzi2Research Laboratory Immunology & Inflammation, Clinical Institute Humanitas, IRCCS, Milan, ItalyChiara Leuzzi3Department of Cardiology, University of Modena and Reggio Emilia, Modena, ItalyRoberto D'Amico1Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, ItalyPiera Boschetto4Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyMaria Grazia Modena3Department of Cardiology, University of Modena and Reggio Emilia, Modena, ItalyAlberto Mantovani2Research Laboratory Immunology & Inflammation, Clinical Institute Humanitas, IRCCS, Milan, ItalyLeonardo M. Fabbri1Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, ItalyBianca Beghé1Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy
- Association of β2-adrenoreceptor genotypes with prevention of COPD exacerbations by tiotropium or salmeterol in the POET-COPD® trialBy Harald Koegler, Klaus F. Rabe, Kai M. Beeh, Thomas Glaab, Hendrik Schmidt, Leonardo M. Fabbri and Claus VogelmeierHarald Koegler1Medical Affairs Germany, Boehringer Ingelheim, Ingelheim, GermanyKlaus F. Rabe2Center of Pulmonary Diseases and Thoracic Surgery, Hospital Grosshansdorf, GermanyKai M. Beeh3Insaf, Respiratory Research Institute, Wiesbaden, GermanyThomas Glaab1Medical Affairs Germany, Boehringer Ingelheim, Ingelheim, GermanyHendrik Schmidt4Biometrics and Data Management, Boehringer Ingelheim, Ingelheim, GermanyLeonardo M. Fabbri5Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyClaus Vogelmeier6Division for Pulmonary Diseases, Hospital of the Universities of Giessen and Marburg, Marburg, Germany
- Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary diseaseBy Piera Boschetto, Ilaria Campo, Mariarita Stendardo, Enrico Casimirri, Carmine Tinelli, Claudio Ceconi, Alessandro Fucili, Alfredo Potena, Licia Ballerin, Leonardo M. Fabbri and Maurizio LuisettiPiera Boschetto1Department of Clinical and Experimental Medicine, University of Ferrara, ItalyIlaria Campo2Department of Molecular Medicine, Section of Pneumology, IRCCS Policlinico San Matteo Foundation, University of Pavia, ItalyMariarita Stendardo1Department of Clinical and Experimental Medicine, University of Ferrara, ItalyEnrico Casimirri1Department of Clinical and Experimental Medicine, University of Ferrara, ItalyCarmine Tinelli3Unit of Statistics and Biometry, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyClaudio Ceconi1Department of Clinical and Experimental Medicine, University of Ferrara, ItalyAlessandro Fucili1Department of Clinical and Experimental Medicine, University of Ferrara, ItalyAlfredo Potena4Respiratory Physio-Pathology Unit, Hospital-University of Ferrara, ItalyLicia Ballerin4Respiratory Physio-Pathology Unit, Hospital-University of Ferrara, ItalyLeonardo M. Fabbri5Department of Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyMaurizio Luisetti2Department of Molecular Medicine, Section of Pneumology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Italy
- The utility of echocardiography in elderly smokers with COPD and of spirometry in elderly smokers with CHFBy Alessia Verduri, Bianca Beghé, Barbara Bottazzi, Alessandro Fucili, Alberto Papi, Licia Ballerin, Mariarita Stendardo, Alberto Mantovani, Claudio Ceconi, Leonardo M. Fabbri and Piera BoschettoAlessia Verduri1Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyBianca Beghé1Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyBarbara Bottazzi2Research Laboratory Immunology & Inflammation, Humanitas Clinical and Research Center, Rozzano, Milano, ItalyAlessandro Fucili3Department of Medical Sciences, University of Ferrara, Ferrara, ItalyAlberto Papi3Department of Medical Sciences, University of Ferrara, Ferrara, ItalyLicia Ballerin4Respiratory Physio-Pathology Unit, Hospital-University of Ferrara, Ferrara, ItalyMariarita Stendardo3Department of Medical Sciences, University of Ferrara, Ferrara, ItalyAlberto Mantovani2Research Laboratory Immunology & Inflammation, Humanitas Clinical and Research Center, Rozzano, Milano, Italy5Department of Translational Medicine, University of Milan, Milano, ItalyClaudio Ceconi3Department of Medical Sciences, University of Ferrara, Ferrara, ItalyLeonardo M. Fabbri1Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyPiera Boschetto3Department of Medical Sciences, University of Ferrara, Ferrara, Italy
- Long-term macrolide treatment for chronic respiratory diseaseBy Paolo Spagnolo, Leonardo M. Fabbri and Andrew BushArticle | Published in 2012 in European Respiratory JournalPaolo Spagnolo*Section of Respiratory Diseases, Dept of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Policlinico di Modena, ItalyLeonardo M. Fabbri*Section of Respiratory Diseases, Dept of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Policlinico di Modena, ItalyAndrew Bush#Imperial College and Royal Brompton Harefield NHS Foundation Trust, London UK
- Ageing and multimorbidityBy Jeffrey M. Drazen and Leonardo M. FabbriJeffrey M. Drazen1Brigham and Women’s Hospital, Pulmonary and Critical Care, Boston, MA, USALeonardo M. Fabbri2University of Modena and Reggio Emilia, Respiratory Disease Unit, Modena, Italy
- Symptomatic, frail, elderly patients: the urgent need for comprehensive assessment and managementBy Enrico Clini, Bianca Beghe and Leonardo M. FabbriEnrico Clini1Villa Pineta di Gaiato, University of Modena and Reggio Emilia, Pavullo nel Frignano Modena, ItalyBianca Beghe2Department of Oncology, Hematology and Respiratory Diseases, Polyclinic of Modena, University of Modena and Reggio Emilia, Modena, ItalyLeonardo M. Fabbri2Department of Oncology, Hematology and Respiratory Diseases, Polyclinic of Modena, University of Modena and Reggio Emilia, Modena, Italy
- ERS Handbook of Respiratory Medicine (out of print)
Edited by Paolo Palange and Anita K. SimondsBook | Published in 2013DOI: 10.1183/9781849840415-hba02ISBN (electronic): 978-1-84984-041-5 - Salmeterol/fluticasone combination instead of indacaterol or vice-versa?By Leonardo M. Fabbri and Alvar AgustiLeonardo M. Fabbri1Respiratory Disease Unit, University of Modena and Reggio Emilia, Modena, ItalyAlvar Agusti2Hospital Clinic de Barcelona, CIBER en Enfermedades Respiratorias (CIBERES), Barcelona, Spain3Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlvar AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authors
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar A. Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlvar A. AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section
- Comorbidities in elderly smokers with COPD or CHFBy Bianca Beghé, Alessia Verduri, Martina Garofalo, Sara Balduzzi, Monica Bortolotti, Michela Schito, Enrico Clini, Leonardo M. Fabbri and Piera BoschettoBianca Beghé1Respiratory Unit, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyAlessia Verduri1Respiratory Unit, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyMartina Garofalo1Respiratory Unit, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalySara Balduzzi1Respiratory Unit, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyMonica Bortolotti1Respiratory Unit, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyMichela Schito2Department of Medical Sciences, University of Ferrara, Ferrara, ItalyEnrico Clini1Respiratory Unit, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyLeonardo M. Fabbri1Respiratory Unit, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyPiera Boschetto2Department of Medical Sciences, University of Ferrara, Ferrara, Italy
- Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapyBy Fernando J. Martinez, Peter M.A. Calverley, Udo-Michael Goehring, Rachel Hodge, Leonardo M. Fabbri and Klaus F. RabeFernando J. Martinez1Department of Medicine, Weill Cornell Medical College, New York, United StatesPeter M.A. Calverley2Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United KingdomUdo-Michael Goehring3Takeda Development Centre Europe Ltd, Takeda Development Centre Europe Ltd, London, United KingdomRachel Hodge3Takeda Development Centre Europe Ltd, Takeda Development Centre Europe Ltd, London, United KingdomLeonardo M. Fabbri4Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyKlaus F. Rabe5Department of Medicine, Christian-Albrechts University Kiel, Kiel, Germany
- LATE-BREAKING ABSTRACT: PT003, a novel co-suspension MDI glycopyrronium/formoterol fixed-dose combination is superior to monocomponents in patients with COPDBy Klaus Rabe, Fernando Martinez, Roberto Rodriguez-Roisin, Leonardo M. Fabbri, Gary T. Ferguson, Paul Jones, Stephen Rennard, Michael Golden, Patrick Darken, Chad Orevillo, Tracy Fischer and Colin ReisnerKlaus Rabe1Lungen Clinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, GermanyFernando Martinez2Department of Internal Medicine, Weill Cornell Medical College, New York, NY United StatesRoberto Rodriguez-Roisin3Servei de Pneumologia, Institut del Tòrax, Hospital Clinic-IDIBAPS-CIBERES, Barcelona, SpainLeonardo M. Fabbri4Department of Oncology, Haematology and Respiratory Diseases, University of Modena, Modena, ItalyGary T. Ferguson5COPD, Pulmonary Research Institute of Southeast Michigan, Livonia, MI United StatesPaul Jones6Institute for Infection and Immunity, St. George's, University of London, London, United KingdomStephen Rennard7Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE United StatesMichael Golden8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesPatrick Darken8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesChad Orevillo8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesTracy Fischer8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesColin Reisner8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United States
- ERS Handbook of Respiratory Medicine
Edited by Paolo Palange and Gernot RohdeBook | Published in 2019DOI: 10.1183/9781849840798.erh01ISBN (electronic): 978-1-84984-079-8
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series
